Global pharmaceutical company Allergan has confirmed that it has received Food and Drug Administration (FDA) approval to market JUVÉDERM VOLLURE XC for the correction of moderate to severe facial wrinkles and folds in the US.
A new show will air on Channel 4 that will allow patients to pitch their desired surgery to a panel of judges, called ‘The Surjury’.
A new textbook that encompasses a wide range of topics in aesthetic medicine has been released.
The British Association of Aesthetic Plastic Surgeons (BAAPS) has issued a statement supporting a petition to make it illegal for practitioners to offer cosmetic surgery without appropriate insurance.
The Lightfusion LED platform has been approved by the US Food and Drug Administration (FDA) as a Class 2 medical device for the treatment of periorbital wrinkles.
On September 29 guests were welcomed to Bristol Plastic Surgery for the S-Thetics medical aesthetic clinic launch.
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Xeomin® has received cosmetic approval from the US Food and Drug Administration (FDA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.
Alma lasers, distributed in the UK and Ireland by ABC Lasers, has received a new FDA clearance indication for the Soprano Xli Blue laser for treatment of all skin types including black skin types and sun tanned skin.
Aesthetic organisations have welcomed the launch of the Breast and Cosmetic Implant Registry (BCIR) that was launched on October 15.